ENTX - Entera Bio Ltd
IEX Last Trade
1.67
0.020 1.198%
Share volume: 11,103
Last Updated: Fri 30 Aug 2024 09:59:49 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.65
0.02
1.21%
Fundamental analysis
27%
Profitability
25%
Dept financing
21%
Liquidity
45%
Performance
25%
Performance
5 Days
-2.34%
1 Month
5.70%
3 Months
-27.71%
6 Months
33.60%
1 Year
149.89%
2 Year
23.70%
Key data
Stock price
$1.67
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.52 - $3.35
52 WEEK CHANGE
$1.49
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Adam Gridley
Region: US
Website: http://www.enterabio.com/
Employees: 15
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: http://www.enterabio.com/
Employees: 15
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
entera bio ltd. is a biotechnology company located in israel.
Recent news